1-(5-(4-amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-4-fluoroindolin-1-yl)-2-(6-methylpyridin-2-yl)ethanone(CAS号:1337532-29-2)

GSK2656157 抑制剂

基本信息

1-(5-(4-amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-4-fluoroindolin-1-yl)-2-(6-methylpyridin-2-yl)ethanone

CAS号

1337532-29-2

分子式

C23H21FN6O

分子量

416.46 g/mol

Quick Actions

基本物理性质

沸点

744.6±60.0°C at 760 mmHg

溶解度

Insuluble (3.4E-3 g/L) (25 ºC),

SMILES

CC1=NC(=CC=C1)CC(=O)N2CCC3=C2C=CC(=C3F)C4=CN(C5=NC=NC(=C45)N)C

InChI

InChI=1S/C23H21FN6O/c1-13-4-3-5-14(28-13)10-19(31)30-9-8-16-18(30)7-6-15(21(16)24)17-11-29(2)23-20(17)22(25)26-12-27-23/h3-7,11-12H,8-10H2,1-2H3,(H2,25,26,27)

InChIKey

PRWSIEBRGXYXAJ-UHFFFAOYSA-N

LogP

3.1918200000000017

拓扑极性表面积

89.93 Ų

氢键供体/受体

2 / 7

复杂度

666

分类与用途

安全信息

查看安全信息

危险说明

H302

同义词与参考文献

英文

  • GSK2656157
  • 1-(5-(4-Amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-4-fluoroindolin-1-yl)-2-(6-methylpyridin-2-yl)ethanone
  • 1-?[5-?(4-?amino-?7-?methyl-?7H-?pyrrolo[2,?3-?d]?pyrimidin-?5-?yl)?-?4-?fluoro-?2,?3-?dihyd
  • GSK-2656157
  • AK174904
  • 1-(5-(4-amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-4-fluoroindolin-1-yl)-2-(6-methylpyridin-2-yl)ethan-1-one
  • C23H21FN6O
  • PRWSIEBRGXYXAJ-UHFFFAOYSA-N
  • GTPL9544
  • HMS3652P16
  • AOB87106
  • BCP09007
  • s7033
  • BDBM50442166
  • 2448AH
  • SB19409
  • compound
  • 1-[5-(4-Amino-7-methylpyrrolo[2,3-d]pyrimidin-5-yl)-4-fluoro-2,3-dihydroindol-1-yl]-2-(6-methylpyrid
  • 1-[5-(4-Amino-7-methylpyrrolo[2,3-d]pyrimidin-5-yl)-4-fluoro-2,3-dihydroindol-1-yl]-2-(6-methylpyridin-2-yl)ethanone
  • CHEMBL2441340
  • 1-(5-(4-amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-4-fluoroindolin-1-yl)-2-(6-methylpyridin-2-yl)ethanone
  • 1-[5-(4-Amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-4-fluoro-2,3-dihydro-1H-indol-1-yl]-2-(6-methyl-2-pyridinyl)-ethanone
  • 1-[5-(4-Amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-4-fluoro-2,3-dihydro-1H-indol-1-yl]-2-(6-methyl-2-pyridinyl)ethanone
  • PERK inhibitor GSK2656157
  • HMS3868L13
  • 1-(5-{4-AMINO-7-METHYLPYRROLO[2,3-D]PYRIMIDIN-5-YL}-4-FLUORO-2,3-DIHYDROINDOL-1-YL)-2-(6-METHYLPYRIDIN-2-YL)ETHANONE
  • AKOS025404913
  • NCGC00386314-01
  • AC-32973
  • SW222243-1
  • NCGC00386314-03
  • HY-13820
  • 1-[5-(4-Amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-4-fluoro-2,3-dihydro-1H-indol-1-yl]-2-(6-methyl-2-pyridinyl)-ethanone; 5-[4-Fluoro-1-[(6-methyl-2-pyridinyl)acetyl]-2,3-dihydro-1H-indol-5-yl]-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
  • 5-{4-fluoro-1-[(6-methyl-2-pyridinyl)acetyl]-2,3-dihydro-1H-indol-5-yl}-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
  • CHEBI:139047
  • 1337532-29-2
  • J-006434
  • AS-35165
  • CCG-268839
  • CS-3262
  • 1-[5-(4-amino-7-methylpyrrolo[2,3-d]pyrimidin-5-yl)-4-fluoro-2,3-dihydroindol-1-yl]-2-(6-methylpyridin-2-yl)ethanone
  • SCHEMBL870782
  • compound 6 [PMID: 24900593]
  • GSK 2656157
  • DA-31727
  • MFCD27997885
  • AGN-PC-09SWN4
  • EX-A439
  • 5-{4-fluoro-1[(6-methyl-2-pyridinyl)acetyl]-2,3-dihydro-1H-indol-5-yl}-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
  • DTXSID101103941
  • HMS3747M09

中文

  • 5-[4-氟-1-[(6-甲基-2-吡啶基)乙酰基]-2,3-二氢-1H-吲哚-5-基]-7-甲基-7H-吡咯并[2,3-D]嘧啶-4-胺
  • GSK2656157 抑制剂

MDL_Number

MFCD27997885

CAS号

1337532-29-2

供应商信息

供应商名称 会员等级 认证状态 主要类别 最小订购量 操作
中国中国 - 北京索莱宝科技有限公司
中国中国 - 上海陌孚医药科技有限公司
中国中国 - 上海珞珐生化科技有限公司
中国中国 - 上海瀚思化工有限公司
中国中国 - 上海绩祥生物科技有限公司
中国中国 - 金锦乐(湖南)化学有限公司
中国中国 - 上海源溪生物科技有限公司
德国德国 - DaXem有限公司

相关文献

Contents list

Front/Back Matter

DOI: 10.1039/D0CC90139C

Novel aqueous amine looping approach for the direct capture, conversion and storage of CO2 to produce magnesium carbonate

Meishen Liu, Hassnain Asgar, Soenke Seifert, Greeshma Gadikota

2019-11-25 Paper

DOI: 10.1039/C9SE00316A

Co9S8 integrated into nitrogen/sulfur dual-doped carbon nanofibers as an efficient oxygen bifunctional electrocatalyst for Zn–air batteries

Weiwei Zheng, Jiangquan Lv, Huabin Zhang, Hai-Xia Zhang, Jian Zhang

2019-12-16 Communication

DOI: 10.1039/C9SE01130G

Synthesis and optical and electronic properties of one-dimensional sulfoxonium-based hybrid metal halide (CH3)3SOPbI3

Shiqiang Bai, Xizu Wang, Si Yin Tee, Siew Lay Lim, Lin Ke, Surani B. Dolmanan, Coryl Jing Jun Lee, Poh Chong Lim, Xiang Yao, Jishan Wu

2021-05-10 Communication

DOI: 10.1039/D1CC01386F

Surface structure-dependent electrocatalytic reduction of CO2 to C1 products on SnO2 catalysts

Minling Fang, Zhiping Zheng, Jiayu Chen, Qian Chen, Deyu Liu, Binbin Xu, Jianyang Wu, Qin Kuang

2019-12-02 Paper

DOI: 10.1039/C9SE00678H

Highly efficient and durable III–V semiconductor-catalyst photocathodes via a transparent protection layer

Shinjae Hwang, James L. Young, Rachel Mow, Mengjun Li, Hongbin Yang, Philip E. Batson, Martha Greenblatt, Myles A. Steiner, Daniel Friedman, Todd G. Deutsch, Eric Garfunkel

2020-01-03 Paper

DOI: 10.1039/C9SE01264H

An aminophosphonate ester ligand-containing platinum(ii) complex induces potent immunogenic cell death in vitro and elicits effective anti-tumour immune responses in vivo

Ke-Bin Huang, Feng-Yang Wang, Hai-Wen Feng, Hejiang Luo, Yan Long, Albert S. C. Chan, Rong Liu, Huahong Zou, Zhen-Feng Chen, Yan-Cheng Liu, You-Nian Liu, Hong Liang

2019-09-23 Communication

DOI: 10.1039/C9CC06563F

An overview of latest advances in exploring bioactive peptide hydrogels for neural tissue engineering

Pooja Sharma, Vijay Kumar Pal, Sangita Roy

2021-04-05 Review Article

DOI: 10.1039/D0BM02049D